Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Reducing harm in the treatment of multidrug-resistant tuberculosis.

Reducing harm in the treatment of multidrug-resistant tuberculosis. Lancet. 2018 09 08; 392(10150):797-798.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.